Hip Diseases
Conditions
Interventions
Group A:Group A received fascia iliaca block: 133 mg liposomal bupivacaine + saline, totaling 40 ml.
Group B:Group B received fascia iliaca block: 0.375% ropivacaine + saline, totaling 40 ml.
Sponsors
Bao'an District People's Hospital, Shenzhen.
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients undergoing hip fracture surgery under general anesthesia with tracheal intubation, including artificial femoral head replacement or total hip arthroplasty, aged 60 to 85 years, with ASA classification I to III.
Exclusion criteria
Exclusion criteria: Patients who are allergic to local anesthetics, have abnormal coagulation test results, have severe cardiopulmonary diseases preoperatively, have liver or kidney dysfunction, are morbidly obese, have skin lesions or infections in the groin area, have chronic pain, are unable to cooperate with NRS scoring, or have a history of opioid abuse are considered unsuitable for clinical trials by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 15-item Quality of Recovery Scale (QoR-15) at 72 hours; | — |
Secondary
| Measure | Time frame |
|---|---|
| The higher the concentration,Fewer opioids;Numerical Rating Scale for Pain;Muscle Strength Recovery Time; | — |
Countries
China
Contacts
Public ContactXie Yuting
Bao'an District People's Hospital, Shenzhen.
Outcome results
None listed